Transcripts

22-11-04 China Biotech Services Holdings Limited Provides Unaudited Consolidated Earnings Guidance for the Nine Months Ended 30 September 2022 CI
22-08-03 China Biotech Services Holdings Limited Provides Consolidated Earnings Guidance for the Six Months Ending 30 June 2022 CI
22-05-05 China Biotech Services Holdings Limited Provides Earnings Guidance for the Three Months Ended 31 March 2022 CI
22-03-07 China Biotech Services Holdings Limited Provides Unaudited Consolidated Earnings Guidance for the Year Ended 31 December 2021 CI
21-08-02 China Biotech Services Holdings Limited Provides Unaudited Consolidated Earnings Guidance for the Six Months Ended June 30, 2021 CI
21-03-01 China Biotech Services Holdings Limited Provides Unaudited Consolidated Earnings Guidance for the Year Ended December 31, 2020 CI
20-10-27 China Biotech Services Holdings Limited Provides Earnings Guidance for the Third Quarter Ended 30 September 2020 CI
20-08-03 China Biotech Services Holdings Limited Provides Unaudited Consolidated Earnings Guidance for the Six Months Ended 30 June 2020 CI
20-05-04 China Biotech Services Holdings Limited Provides Group Earnings Guidance for the First Quarter of 2020 CI
20-02-28 China Biotech Services Holdings Limited Provides Earnings Guidance for the Year Ended December 31, 2019 CI
19-10-30 China Biotech Services Holdings Limited Provides Earnings Guidance for the Third Quarter 2019 CI
19-07-30 China Biotech Services Holdings Limited Provides Consolidated Earnings Guidance for the Six Months Ended 30 June 2019 CI
18-10-31 China Biotech Services Holdings Limited Provides Unaudited Consolidated Earnings Guidance for the Nine Months Ended September 30, 2018 CI
18-07-27 China Biotech Services Holdings Limited Provides Consolidated Earnings Guidance for the Six Months Ended 30 June 2018 CI
17-04-10 Rui Kang Pharmaceutical Group Investments Limited Provides Consolidated Earnings Guidance for the Three Months Ended March 31, 2017 CI
17-01-06 Rui Kang Pharmaceutical Group Investments Limited Provides Consolidated Earnings Guidance for the Year Ended December 31, 2016 CI
16-10-17 Rui Kang Pharmaceutical Group Investments Limited Provides Earnings Guidance for the Nine Months Ended 30 September 2016 CI
16-07-11 Rui Kang Pharmaceutical Group Investments Limited Provides Group Earnings Guidance for Six Months Ended 30 June 2016 CI
16-04-11 Rui Kang Pharmaceutical Group Investments Limited Provides Group Earnings Guidance for the Three Months Ended March 31, 2016 CI
16-01-08 Rui Kang Pharmaceutical Group Investments Limited Provides Earnings Guidance for the Year Ended 31 December 2015 CI
15-10-28 Rui Kang Pharmaceutical Group Investments Limited Provides Earnings Guidance for the Nine Months Ended September 30, 2015 CI
15-07-10 Rui Kang Pharmaceutical Group Investments Limited Provides Earnings Guidance for the Six Months Ended 30 June 2015 CI
15-04-29 Rui Kang Pharmaceutical Group Investments Limited Provides Earnings Guidance for the Three Months Ended 31 March 2015 CI
15-02-27 Rui Kang Pharmaceutical Group Investments Limited Provides Outlook for the Year Ended December 31, 2014; Provides Guidance for Impairment Loss on Goodwill for the Year Ended December 31, 2014 CI
14-07-28 Rui Kang Pharmaceutical Group Investments Limited Provides Earnings Guidance for the Six Months Ended June 30, 2014 CI
No results match your criteria
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!